1. Home
  2. Live Updates
  3. Akeso inc

Live Breaking News & Updates on Akeso inc

Stay informed with the latest breaking news from Akeso inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Akeso inc and stay connected to the pulse of your community

Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024

Conference Call to be Held at 9:00am ET

...

Miami , Florida , United-states , Japan , United-kingdom , Australia , Canada , Menlo-park , California , China , Exchange-commission

Summit Therapeutics (NASDAQ:SMMT) & VBI Vaccines (NASDAQ:VBIV) Head-To-Head Survey

Summit Therapeutics (NASDAQ:SMMT) & VBI Vaccines (NASDAQ:VBIV) Head-To-Head Survey
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Florida , United-states , Canada , Cambridge , Cambridgeshire , United-kingdom , Miami , Massachusetts , Coalition-for-epidemic-preparedness-innovations , Scivac-therapeutics-inc , Summit-therapeutics-inc

Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum

Summit Therapeutics Inc. today announced that it will participate in and present at the Stifel 2024 Targeted Oncology Forum, which will be held virtually April 16-17, 2024. Dr. Maky Zanganeh, Chief...

Miami , Florida , United-states , Menlo-park , California , Japan , China , Australia , Canada , United-kingdom , Maky-zanganeh , Robertw-duggan

Oral report | The positive interim analysis results from the Phase III clinical study of Akeso's Cadonilimab (PD-1/CTLA-4 BsAb) plus chemotherapy as first-line treatment for advanced gastric cancer presented at 2024 AACR

SAN DIEGO, April 8, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the positive interim analysis results from Phase III clinical study of Cadonilimab (PD-1/CTLA-4 BsAb) combined with XELOX

United-states , American , Akeso-inc , American-association-for-cancer-research , Prnewswire-akeso-inc , Cancer-research ,

Cadomilimab Plus Oxaliplatin and Capecitabine Leads to Survival Benefit in Gastric/GEJ Cancer

Cadomilimab plus oxaliplatin and capecitabine leads to survival benefit in gastric/GEJ adenocarcinoma, regardless of PD-L1 expression.

San-diego , California , United-states , Peking , Beijing , China , Jiafu-ji , University-hospital , China-national-medical-products-administration , Akeso-inc , Peking-university-hospital , Enrollment-criteria

Oral report | The positive interim analysis results from the Phase III clinical study of Akeso's Cadonilimab (PD-1/CTLA-4 BsAb) plus chemotherapy as first-line treatment for advanced gastric cancer presented at 2024 AACR

SAN DIEGO, April 9, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the positive interim analysis results from Phase III clinical study of

Thailand , United-states , American , Akeso-inc , American-association-for-cancer-research , Cancer-research , Thailand-business ,

Akeso Marks Profit Milestone With Swift Rights Issue - Summit Therapeutics (NASDAQ:SMMT)

Key Takeaways: Akeso swung to an annual profit of 1.94 billion yuan, boosted by licensing income of 2.92 billion yuan The next highly anticipated product in the firm’s drug pipeline is ivonescimab, the first PD-1/VEGF bispecific antibody to enter Phase III clinical trials By Molly Wen

Hong-kong , United-states , Tianqing , Zhejiang , China , Canada , Japan , Chinese , Molly-wen , Akeso-inc , Chia-tai-tianqing-pharmaceutical-group , Citibank

China Powerwoman's Akeso Raises $150 Mln After First Profit

Tie-up with Summit Therapeutics boosted revenue

Hong-kong , China , Xia-yu , Michelle-xia , Wang-laichun , Newcastle-university , Sun-yat-sen-university , University-of-louisville-school-medicine , Hong-kong-stock-exchange , Akeso-inc , Forbes-china , Nasdaq-listed-summit

The promising results of a phase II clinical study for Akeso's Cadonilimab (PD-1/CTLA-4) combined standard treatment for first-line treatment of R/M cervical cancer has been published in Clinical Canc

The promising results of a phase II clinical study for Akeso's Cadonilimab (PD-1/CTLA-4) combined standard treatment for first-line treatment of R/M cervical cancer has been published in Clinical Canc
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong-kong , China , United-states , American , Prnewswire-akeso , China-national-medical-products-administration , American-society-of-clinical-oncology , Clinical-cancer-research , American-association-for-cancer-research , Akeso-inc , Contact-akeso-business-development , American-association

Summit Therapeutics to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference

Summit Therapeutics to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Canada , Australia , Menlo-park , California , United-states , Japan , China , United-kingdom , Miami , Florida , Robertw-duggan , Maky-zanganeh